The U.S. Food and Drug Administration (FDA) recently launched the agency’s first mobile application aimed at expediting updates to the public about drug shortages. The free app identifies current drug shortages, informs the public of resolved shortages and announces drug discontinuations. App users can search or browse by a drug’s generic name or active ingredient, and browse by thera...

Read More

The World Health Organization (WHO) released its first set of guidelines on the prevention and treatment of chronic hepatitis B. The guidelines cover the full spectrum of care, including who needs treatment, what medicines to use and how to monitor patients long-term. Key recommendations include: the use of a few simple noninvasive tests to assess the stage of liver disease to help identif...

Read More

On March 6, 2015, the U.S. Food and Drug Administration (FDA) announced the approval of Zarxio® (filgrastim-sndz) as a biosimilar to Neupogen®. The formulation of Zarxio differs from that of U.S.-licensed Neupogen in one inactive component, and a review of evidence demonstrated that “there are no clinically meaningful differences between Zarxio and U.S.-licensed Neupogen,” acco...

Read More

MPA and Pharmacy Services Inc. (PSI) are pleased to offer the Executive Fellowship, a year-long program that provides a strong foundation in business, leadership, policy and association management. Applications are being accepted through Friday, April 17 for the 2015-2016 program. If you have ever thought about training to gain more business, management, and leadership skills or are interested in...

Read More

Gov. Rick Snyder recently announced the appointment of Cynthia Boston of Utica to the Michigan Board of Pharmacy. The 11-member board is responsible for regulating and inspecting the practice of pharmacy and drugs manufactured and distributed in the state. Cynthia is a pharmacy technician working in medication reconciliation at Crittenton Hospital Medical Center, where she helped to prepare the ho...

Read More